RA Capital Management - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$35,757,583
+77.3%
9,459,678
+214.3%
0.70%
+84.8%
Q2 2023$20,164,843
+2.9%
3,009,6780.0%0.38%
-14.2%
Q1 2023$19,593,004
-23.7%
3,009,6780.0%0.44%
-14.8%
Q4 2022$25,672,553
+121.3%
3,009,678
+72.8%
0.52%
+154.1%
Q4 2021$11,603,000
-33.3%
1,742,1860.0%0.20%
-14.9%
Q3 2021$17,387,000
-67.7%
1,742,1860.0%0.24%
-72.1%
Q2 2021$53,816,000
-29.2%
1,742,1860.0%0.86%
-24.6%
Q1 2021$76,012,000
-5.8%
1,742,1860.0%1.15%
+1.5%
Q4 2020$80,733,0001,742,1861.13%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders